Vycor Medical Inc
VYCO· OTC
Released Nov 14, 2022, during market hours
10-Q filed Nov 14, 2022, 45 days after period end · 0001493152-22-031733
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $309.97K | $332.09K | $275.93K | $322.88K |
| Net Income | -$114.81K | $3.69K | -$198.29K | -$209.61K |
| EPS Diluted | -$0.01 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.01 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.